The tumor stem cell concept-Implications for endocrine tumors?

Molecular and Cellular Endocrinology

Volumn 300, Issue 1-2, 2009, Pages 158-163

  Lichtenauer, Urs D ^a   Beuschlein, Felix ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cancer stem cell; Endocrine tumor; Side population; Tumor stem cell

Indexed keywords

CANCER STEM CELL; CELL CLONE; CELL CYCLE REGULATION; CELL PROLIFERATION; ENDOCRINE TUMOR; GENOME; GENOMICS; HUMAN; HYPOTHESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; THEORETICAL MODEL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; BIOLOGICAL MARKERS; CELL SEPARATION; ENDOCRINE GLAND NEOPLASMS; FLUORESCENT DYES; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 59649123338     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.10.037     Document Type: Review

References (50)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3983-3988
2. Bailey J.M., Singh P.K., and Hollingsworth M.A. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell. Biochem. 102 (2007) 829-839
3. Bapat S.A., Mali A.M., Koppikar C.B., and Kurrey N.K. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65 (2005) 3025-3029
4. Barker N., and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5 (2006) 997-1014
5. Beachy P.A., Karhadkar S.S., and Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432 (2004) 324-331
6. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., and Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40 (2008) 499-507
7. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
8. Burstein D.E., Nagi C., Wang B.Y., and Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum. Pathol. 35 (2004) 465-473
9. Byrne A.M., Bouchier-Hayes D.J., and Harmey J.H. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9 (2005) 777-794
10. Challen G.A., and Little M.H. A side order of stem cells: the SP phenotype. Stem Cells 24 (2006) 3-12
11. Chen J., Crabbe A., van Duppen V., and Vankelcom H. The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population. Mol. Endocrinol. 20 (2006) 3293-3307
12. Dean M., Fojo T., and Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5 (2005) 275-284
13. Fischer M., Schmidt M., Klingenberg S., Eaves C.J., von Kalle C., and Glimm H. Short-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotype. Blood 108 (2006) 2121-2123
14. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
15. Goodell M.A., Jackson K.A., Majka S.M., Mi T., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., and Hirschi K.K. Stem cell plasticity in muscle and bone marrow. Ann. N. Y. Acad. Sci. 938 (2001) 208-218 (Discussion 218-220)
16. Hart A.H., Hartley L., Parker K., Ibrahim M., Looijenga L.H., Pauchnik M., Chow C.W., and Rovv L. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104 (2005) 2092-2098
17. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14228-14233
18. Immervoll H., Hoem D., Sakariassen P.O., Steffensen O.J., and Molven A. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 8 (2008) 48
19. Kageyama K., Ikeda H., Nigawara T., Sakihara S., and Suda T. Expression of adrenocorticotropic hormone, prolactin and transcriptional factors in clinically nonfunctioning pituitary adenoma. Endocr. J. 54 (2007) 961-968
20. Kristensen D.M., Sonne S.B., Ottensen A.M., Perrett R.M., Nielsen J.E., Almstrup K., Skakkebaek N.E., Leffers H., and Meyts E.R. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol. Cell. Endocrinol. 288 (2008) 111-118
21. Lensch M.W., Daheron L., and Schlaeger T.M. Pluripotent stem cells and their niches. Stem Cell Rev. 2 (2006) 185-201
22. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030-1037
23. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66 (2006) 4553-4557
24. Li X.N., Shu Q., Su J.M., Adesina A.M., Wong K.K., Perlaky L., Antalffy B.A., Blaney S.M., and Lau C.C. Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol. Appl. Neurobiol. 33 (2007) 67-76
25. Lichtenauer U.D., Shapiro I., Geiger K., Quinkler M., Fassnacht M., Nitschke R., Ruckauer K.D., and Beuschlein F. Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 149 (2008) 1314-1322
26. Looijenga L.H., Hersmus R., Gillis A.J., Pfundt R., Stoop H.J., van Gurp R.J., Veltman J., Beverloo H.B., van Drunen E., van Kessel A.G., Pera R.R., Schneider D.T., Summersgill B., Shipley J., McIntyre A., van der Spek P., Schoenmakers E., and Oosterhuis J.W. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res. 66 (2006) 290-302
27. Looijenga L.H., Stoop H., de Leeuw H.P., de Gouveia Brazao C.A., Gillis A.J., van Roozendaal K.E., van Zoelen E.J., Weber R.F., Wolffenbuttel K.P., van Dekken H., Honecker F., Bokemeyer C., Perlman E.J., Schneider D.T., Kononen J., Sauter G., and Oosterhuis J.W. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63 (2003) 2244-2250
28. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., and Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
29. Magro G., Gurrera A., Gangemi P., Saita A., and Greco P. Incompletely differentiated (unclassified) sex cord/gonadal stromal tumor of the testis with a "pure" spindle cell component: report of a case with diagnostic and histogenetic considerations. Pathol. Res. Pract. 203 (2007) 759-762
30. Mimeault M., and Batra S.K. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann. Oncol. 18 (2007) 1605-1619
31. Mimeault M., Hauke R., and Batra S.K. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin. Pharmacol. Ther. 83 (2008) 673-691
32. Mimeault M., Hauke R., Mehta P.P., and Batra S.K. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J. Cell. Mol. Med. 11 (2007) 981-1011
33. Mitsutake N., Iwao A., Nagai K., Namba H., Ohtsuru A., Saenko V., and Yamashita S. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148 (2007) 1797-1803
34. Olempska M., Eisenach P.A., Ammerpohl O., Ungefroren H., Fandrich F., and Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat. Dis. Int. 6 (2007) 92-97
35. Olmsted-Davis E.A., Gugala Z., Camargo F., Gannon F.H., Jackson K., Kienstra K.A., Shine H.D., Lindsey R.W., Hirschi K.K., Goodell M.A., Brenner M.K., and Davis A.R. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15877-15882
36. Powers J.F., Evinger M.J., Zhi J., Picard K.L., and Tischler A.S. Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile. Neuroscience 147 (2007) 928-937
37. Preffer F.I., Dombkowski D., Sykes M., Scadden D., and Yang Y.G. Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization. Stem Cells 20 (2002) 417-427
38. Rafii S., Lyden D., Benezra R., Hattori K., and Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat. Rev. Cancer 2 (2002) 826-835
39. Rajpert-De Meyts E., and Hoei-Hansen C.E. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann. N. Y. Acad. Sci. 1120 (2007) 168-180
40. Rubin L.L., and de Sauvage F.J. Targeting the Hedgehog pathway in cancer. Nat. Rev. Drug Discov. 5 (2006) 1026-1033
41. Ruiz i Altaba A., Sanchez P., and Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2 (2002) 361-372
42. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
43. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T., and Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11154-11159
44. Taipale J., and Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411 (2001) 349-354
45. Takano T., and Amino N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid 15 (2005) 432-438
46. Thomas D., Friedman S., and Lin R.Y. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr. Relat. Cancer 15 (2008) 51-58
47. Toren A., Bielorai B., Jacob-Hirsch J., Fisher T., Kreiser D., Moran O., Zeligson S., Givol D., Yitzhaky A., Itskovitz-Eldor J., Kventsel I., Rosenthal E., Amariglio N., and Rechavi G. CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. Stem Cells 23 (2005) 1142-1153
48. Wulf G.G., Luo K.L., Jackson K.A., Brenner M.K., and Goodell M.A. Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica 88 (2003) 368-378
49. Yokoyama K., Mogi C., Miura K., Kuroda K., and Inoue K. Somatotropes maintain their immature cells through Insulin-like growth factor I (IGF-I). Endocr. Pathol. 18 (2007) 174-181
50. Zhang P., Zuo H., Ozaki T., Nakagomi N., and Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol. Int. 56 (2006) 485-489